We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NTRA market cap is 20.79B. The company's latest EPS is USD -1.4086 and P/E is -109.17.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 311.11M | 367.74M | 413.35M | 439.76M | 476.06M |
| Operating Income | -84.54M | -74.31M | -43.9M | -39.34M | -64.74M |
| Net Income | -78.03M | -67.6M | -37.46M | -31.59M | -53.77M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 391.01M | 625.49M | 820.22M | 1.08B | 1.7B |
| Operating Income | -216.28M | -468.17M | -541.04M | -446.25M | -222.29M |
| Net Income | -229.74M | -471.72M | -547.8M | -434.8M | -190.43M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.44B | 1.47B | 1.52B | 1.59B | 1.66B |
| Total Liabilities | 676.37M | 674.09M | 680.47M | 712.42M | 465.32M |
| Total Equity | 765.33M | 794.11M | 836.52M | 878.53M | 1.2B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 932.15M | 1.24B | 1.39B | 1.44B | 1.66B |
| Total Liabilities | 445.92M | 583.18M | 688.73M | 676.37M | 465.32M |
| Total Equity | 486.24M | 653.3M | 705.74M | 765.33M | 1.2B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -246.96M | 27M | 30.99M | 82.78M | 135.66M |
| Investing | 168.5M | 138.26M | 106.2M | 148.74M | 137.62M |
| Financing | 254.46M | 6.47M | 17.51M | 19.23M | 30.2M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -182.51M | -335.24M | -431.5M | -246.96M | 135.66M |
| Investing | -331.46M | -205.19M | 330.34M | 168.5M | 137.62M |
| Financing | 500.85M | 576.19M | 482.64M | 254.46M | 30.2M |
| Market Cap | 20.79B |
| Price to Earnings Ratio | -109.17 |
| Price to Sales Ratio | 12.25 |
| Price to Cash Ratio | 21.98 |
| Price to Book Ratio | 17.39 |
| Dividend Yield | - |
| Shares Outstanding | 135.19M |
| Average Volume (1 week) | 768.73k |
| Average Volume (1 Month) | 1.45M |
| 52 Week Change | 73.92% |
| 52 Week High | 183.00 |
| 52 Week Low | 87.20 |
| Spread (Intraday) | 5.89 (3.78%) |
| Company Name | Natera Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.natera.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
